Literature DB >> 30221157

Will the magnetic resonance imaging proton density fat fraction replace liver biopsy as the gold standard for detecting steatosis?

Masato Yoneda1, Kento Imajo1, Atsushi Nakajima1.   

Abstract

Entities:  

Year:  2018        PMID： 30221157      PMCID： PMC6131261          DOI： 10.21037/hbsn.2018.04.02

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  14 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

2.  [Good clinical practice guidelines for fine needle aspiration biopsy of the liver: past, present and future].

Authors:  J F Cadranel
Journal:  Gastroenterol Clin Biol       Date:  2002-10

Review 3.  AGA technical review on nonalcoholic fatty liver disease.

Authors:  Arun J Sanyal
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

4.  A position statement on NAFLD/NASH based on the EASL 2009 special conference.

Authors:  Vlad Ratziu; Stefano Bellentani; Helena Cortez-Pinto; Chris Day; Giulio Marchesini
Journal:  J Hepatol       Date:  2010-05-07       Impact factor: 25.083

5.  Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis.

Authors:  Michael S Middleton; Elhamy R Heba; Catherine A Hooker; Mustafa R Bashir; Kathryn J Fowler; Kumar Sandrasegaran; Elizabeth M Brunt; David E Kleiner; Edward Doo; Mark L Van Natta; Joel E Lavine; Brent A Neuschwander-Tetri; Arun Sanyal; Rohit Loomba; Claude B Sirlin
Journal:  Gastroenterology       Date:  2017-06-15       Impact factor: 22.682

6.  Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD.

Authors:  Z Permutt; T-A Le; M R Peterson; E Seki; D A Brenner; C Sirlin; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2012-05-03       Impact factor: 8.171

7.  Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.

Authors:  Charlie C Park; Phirum Nguyen; Carolyn Hernandez; Ricki Bettencourt; Kimberly Ramirez; Lynda Fortney; Jonathan Hooker; Ethan Sy; Michael T Savides; Mosab H Alquiraish; Mark A Valasek; Emily Rizo; Lisa Richards; David Brenner; Claude B Sirlin; Rohit Loomba
Journal:  Gastroenterology       Date:  2016-10-27       Impact factor: 22.682

8.  Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.

Authors:  An Tang; Justin Tan; Mark Sun; Gavin Hamilton; Mark Bydder; Tanya Wolfson; Anthony C Gamst; Michael Middleton; Elizabeth M Brunt; Rohit Loomba; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2013-02-04       Impact factor: 11.105

9.  Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

Authors:  J Ludwig; T R Viggiano; D B McGill; B J Oh
Journal:  Mayo Clin Proc       Date:  1980-07       Impact factor: 7.616

10.  Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.

Authors:  Kento Imajo; Takaomi Kessoku; Yasushi Honda; Wataru Tomeno; Yuji Ogawa; Hironori Mawatari; Koji Fujita; Masato Yoneda; Masataka Taguri; Hideyuki Hyogo; Yoshio Sumida; Masafumi Ono; Yuichiro Eguchi; Tomio Inoue; Takeharu Yamanaka; Koichiro Wada; Satoru Saito; Atsushi Nakajima
Journal:  Gastroenterology       Date:  2015-12-08       Impact factor: 22.682
View more
  2 in total

Review 1.  Impaired albumin function: a novel potential indicator for liver function damage?

Authors:  Lejia Sun; Huanhuan Yin; Meixi Liu; Gang Xu; Xiaoxiang Zhou; Penglei Ge; Huayu Yang; Yilei Mao
Journal:  Ann Med       Date:  2019-11-21       Impact factor: 4.709

Review 2.  Kupffer Cells in Non-alcoholic Fatty Liver Disease: Friend or Foe?

Authors:  Jiajia Chen; Xiaoyi Deng; Yongjian Liu; Qiuhua Tan; Guidong Huang; Qishi Che; Jiao Guo; Zhengquan Su
Journal:  Int J Biol Sci       Date:  2020-06-23       Impact factor: 6.580
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.